Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges-Reference-Cited by-同舟云学术

Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges

Published:2021-05-02 Issue:11 Volume:15 Page:2841-2867
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Garcia‐Pelaez José¹²³^ORCID,Barbosa‐Matos Rita¹²⁴^ORCID,Gullo Irene¹²⁵⁶^ORCID,Carneiro Fátima¹²⁵⁶^ORCID,Oliveira Carla¹²⁵^ORCID

Affiliation:

1. i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto Portugal

2. IPATIMUP – Institute of Molecular Pathology and Immunology University of Porto Portugal

3. Doctoral Programme on Biomedicine Faculty of Medicine University of Porto Portugal

4. Doctoral Programme on Cellular and Molecular Biotechnology Applied to Health Sciences (BiotechHealth) ICBAS – Institute of Biomedical Sciences Abel Salazar University of Porto Portugal

5. Department of Pathology FMUP ‐ Faculty of Medicine of the University of Porto Portugal

6. Department of Pathology CHUSJ – Centro Hospitalar Universitário São João Porto Portugal

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12948

Reference93 articles.

1. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications

2. New Elements for an Updated Classification of the Carcinomas of the Stomach

3. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA

4. Gastric carcinoma:A pathobiological classification

5. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances;Nakamura K;Gan,1968

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFIT1 + neutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC);Journal of Translational Medicine;2024-06-19

2. Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species;Heliyon;2024-03

3. E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming;Journal of Experimental Medicine;2024-02-27

4. Management of Diffuse Gastric Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

5. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases;Signal Transduction and Targeted Therapy;2023-11-13